Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gugliotta

Showing results (111-120 of 469) with videos related to

Pageof 47
Sort By:
Haematologica|July 11, 1998
Effect of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on growth and differentiation of the HEL cell lineL Catani, L Gugliotta, M Motta, et al.
American Journal of Respiratory Cell and Molecular Biology|August 23, 2003
Rho kinase inhibition initiates apoptosis in human airway epithelial cellsMichael Moore, Bertha A Marroquin, Wendy Gugliotta, et al.
Leukemia & Lymphoma|March 23, 2010
Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a 'head-to-head comparison'Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|November 23, 2006
Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patientsF Scamardella, M Maconi, L Albertazzi, et al.
The New England Journal of Medicine|January 18, 2013
Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patientJoseph L Gugliotta, Heidi K Goethert, Victor P Berardi, et al.
Expert Review of Hematology|October 3, 2013
Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitorsGabriele Gugliotta, Fausto Castagnetti, Miriam Fogli, et al.
International Journal of Cardiology|October 30, 2015
Acute coronary syndrome (ACS) in patients with essential thrombocytemia (ET). What is the best treatment?G Tortorella, M Calzolari, A Tieghi, et al.
Diabetes Care|August 31, 2004
Prevalence of eating disorders in young patients with type 1 diabetes from two different Italian citiesDario Iafusco, Maurizio Vanelli, Maria Gugliotta, et al.
Diabetes, Nutrition & Metabolism|November 22, 2005
Effectiveness of an uninterrupted procedure to transfer adolescents with Type 1 diabetes from the Paediatric to the Adult Clinic held in the same hospital: eight-year experience with the Parma protocolM Vanelli, S Caronna, B Adinolfi, et al.
Haematologica|July 1, 1992
Reducing the haemorrhagic risk related to splenectomy in patients with severe chronic idiopathic thrombocytopenic purpuraN Vianelli, L Gugliotta, L Boschi, et al.
Pageof 47

Showing results (111-120 of 469) with videos related to

Sort By:
Pageof 47
Haematologica|July 11, 1998
Effect of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on growth and differentiation of the HEL cell lineL Catani, L Gugliotta, M Motta, et al.
American Journal of Respiratory Cell and Molecular Biology|August 23, 2003
Rho kinase inhibition initiates apoptosis in human airway epithelial cellsMichael Moore, Bertha A Marroquin, Wendy Gugliotta, et al.
Leukemia & Lymphoma|March 23, 2010
Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a 'head-to-head comparison'Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|November 23, 2006
Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patientsF Scamardella, M Maconi, L Albertazzi, et al.
The New England Journal of Medicine|January 18, 2013
Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patientJoseph L Gugliotta, Heidi K Goethert, Victor P Berardi, et al.
Expert Review of Hematology|October 3, 2013
Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitorsGabriele Gugliotta, Fausto Castagnetti, Miriam Fogli, et al.
International Journal of Cardiology|October 30, 2015
Acute coronary syndrome (ACS) in patients with essential thrombocytemia (ET). What is the best treatment?G Tortorella, M Calzolari, A Tieghi, et al.
Diabetes Care|August 31, 2004
Prevalence of eating disorders in young patients with type 1 diabetes from two different Italian citiesDario Iafusco, Maurizio Vanelli, Maria Gugliotta, et al.
Diabetes, Nutrition & Metabolism|November 22, 2005
Effectiveness of an uninterrupted procedure to transfer adolescents with Type 1 diabetes from the Paediatric to the Adult Clinic held in the same hospital: eight-year experience with the Parma protocolM Vanelli, S Caronna, B Adinolfi, et al.
Haematologica|July 1, 1992
Reducing the haemorrhagic risk related to splenectomy in patients with severe chronic idiopathic thrombocytopenic purpuraN Vianelli, L Gugliotta, L Boschi, et al.
Pageof 47